Cargando…
Clinical effect of DAPK promoter methylation in gastric cancer: A systematic meta-analysis
BACKGROUND: The loss of death-associated protein kinase (DAPK) gene expression through promoter methylation is involved in many tumors. However, the relationship between DAPK promoter methylation and clinicopathological features of gastric cancer (GC) remains to be done. Therefore, we performed a me...
Autores principales: | Jia, Wenzhuo, Yu, Tao, Cao, Xianglong, An, Qi, Yang, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089088/ https://www.ncbi.nlm.nih.gov/pubmed/27787359 http://dx.doi.org/10.1097/MD.0000000000005040 |
Ejemplares similares
-
Expression and clinical significance of SYNE1 and MAGI2 gene promoter methylation in gastric cancer
por: Qu, Yanjun, et al.
Publicado: (2021) -
Role of CDH13 promoter methylation in the carcinogenesis, progression, and prognosis of colorectal cancer: A systematic meta-analysis under PRISMA guidelines
por: Ye, Meng, et al.
Publicado: (2017) -
Third-line chemotherapy in advanced gastric cancer: A systematic review and meta-analysis
por: Zheng, Yu, et al.
Publicado: (2017) -
Prognostic significance of DAPK promoter methylation in lymphoma: A meta-analysis
por: Wang, Hong, et al.
Publicado: (2019) -
DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis
por: Dai, Lihe, et al.
Publicado: (2016)